Auto-generated event page

Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing

NEW YORK and VANCOUVER, British Columbia, March 02, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) and Zymeworks Inc. (Nasdaq: ZYME) today announced an agreement for...

Score 41 low confidence 2 source posts Updated Mar 2, 2026, 11:12 AM UTC

Track This Event Open Event in App More Signal Pages

Cluster sources

Newest source rows first.

Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing

GlobeNewswire Public Companies • Mar 2, 2026, 11:10 AM UTC

Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing

GlobeNewswire Public Companies • Mar 2, 2026, 11:01 AM UTC

Entity focus

Direct link to post

https://pushme.site/signals/172105-royalty-pharma-and-zymeworks-enter-into-250-million-royalty-backed-note-?utm_source=signal-172105&utm_medium=social&utm_campaign=signal-pages&utm_content=hero

Quick distribution loop

Step 1

Post this live link in threads where users ask how to monitor this event.

Step 2

Point readers to "Track This Event" for immediate conversion into an alert.

Step 3

Reuse entity keywords from this page for targeted follow-up replies.

Back to signal pages Open query hub